Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5
Mani Inc (7730 JP)
Watchlist
35
Analysis
Health Care
•
Japan
MANI, INC. manufactures medical goods and equipment. The Company's products include threads and needles for surgeries, surgical knives for eye surgeries, and dental instruments and equipment.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
21 Mar 2023 09:02
Japan Healthcare: Currency Benefit Seems to Be Fading; Focus Will Be on Underlying Business Strength
As Yen is recovering from its multi-year lows against Dollar this year, export-oriented healthcare companies are expected to significantly...
Tina Banerjee
Follow
361 Views
Share
bullish
•
Vingroup Jsc
•
11 Mar 2023 02:58
MVIS Vietnam Index Rebalance: One Deletion; Float & Capping Changes
There is one deletion from the index, plus a bunch of changes to float and capping factors. One-way turnover is 4.2% and passives need to buy over...
Brian Freitas
Follow
693 Views
Share
bearish
•
Vietjet Aviation
•
12 Sep 2022 02:54
MVIS Vietnam Index Rebalance: One Add, Two Deletes
There is 1 addition and 2 deletions for the MVIS Vietnam Index. There are a lot of float and capping changes that will result in one-way turnover...
Brian Freitas
Follow
434 Views
Share
bearish
•
Mani Inc
•
03 Jul 2022 09:29
Mani Inc (7730 JP): Q2 Result Exceeds Expectation Aided by Demand Recovery; FY22 Guidance Reiterated
I am still bearish on Mani due to its revenue uncertainty caused by high exposure to China. Profitability is expected to decline in second half....
Tina Banerjee
Follow
420 Views
Share
bearish
•
Mani Inc
•
15 Mar 2022 15:21
Mani (7730 JP): Profit to Decline in Q2; China’s Worsening COVID Outbreak to Weigh on H2 Performance
China's worsening COIVD-19 outbreak and consequent lockdowns will negatively impact Mani's financial performance in H2FY22, as China is one of the...
Tina Banerjee
Follow
318 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x